Afuco™ Anti-HBV Surface Antigen ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-147) (CAT#: AFC-TAB-147)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to HBV. It is a human monoclonal antibody directed against the hepatitis B virus.
Specific Inquiry
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Specificity
- Tested positive against native HBV antigen.
- Species Reactivity
- HBV
- Applications
- FuncS, IF, Neut, ELISA, FC, IP
- Conjugate
- Unconjugated
- Generic Name
- Libivirumab
- Related Disease
- Hepatitis B reinfection in liver transplant patients
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- Hep B surface antigen; Hepatitis B Virus major surface antigen; Hepatitis B virus S antigen; Large envelope protein; Large surface protein; LHB; Major surface antigen
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Libivirumab"
DrugMonitor™ Anti-Libivirumab Antibody (VS-1224-YC665)Libivirumab is an investigational monoclonal antibody and an active ingredient in HepeX-B, containing two human monoclonal antibodies against hepatitis B virus (HBV) surface antigen. The DrugMonitor™ Anti-Libivirumab Antibody (VS-1224-YC665) is an anti-drug antibody (ADA) against Libivirumab. This drug-based antibody is raised in mice immunized with the Libivirumab. The anti-Libivirumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Libivirumab in samples.
See other products for "HBV surface antigen"
Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products
Human Antibody Products
Epitope-Specific Antibody Products
MHC Tetramer Products for Virology
IgG Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NAB-1250-sdAb | Recombinant Anti-HBV surface antigen VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-147. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: Inhib, Cyt
Application: ELISA, WB, BLI, SPR
Application: ELISA, WB, BLI, SPR
Application: FC, IB, Block, Inhib, FuncS, ELISA, FACS, IP, IF
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: ELISA, IHC, FC, IP, IF, FuncS
-1.jpg)
Application: FC
Application: Neut, ELISA, IF, IP, FuncS, FC
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
